Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Medulloblastoma × fenofibric acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Medulloblastoma 1 Ependymoma 1

Interventions

Cyclophosphamide 16 Etoposide 11 Temozolomide 10 Magnetic Resonance Spectroscopy 8 Filgrastim 8 Cisplatin 8 Vincristine 7 Radiotherapy 7 Irinotecan 7 Carboplatin 7 X-Rays 6 Phantoms, Imaging 6 Topotecan 5 Specimen Handling 5 Peripheral Blood Stem Cell Transplantation 5 Nuclear Medicine Department, Hospital 5 Thiotepa 4 Biopsy 4 Bevacizumab 4 sargramostim 3 palbociclib 3 olaparib 3 Methotrexate 3 Chemotherapy, Adjuvant 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 sonidegib 2 selpercatinib 2 larotrectinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01356290 2026-02-23

MEMMAT

Medical University of Vienna

Phase 2 Recruiting

Ependymoma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡